Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables

Table 3 Primary and secondary objectives for which combined genetic/clinical scores are expected in the field of non-alcoholic fatty liver disease

Primary objectives	Prediction of hard outcomes (cirrhosis decompensation, hepatocellular carcinoma, liver transplantation)
	Prediction of fibrosis progression
Secondary objectives	Complementary instruments for the diagnosis of NASH and/or advanced fibrosis
	Prediction of response to lifestyle interventions
	Prediction of response to pharmacologic interventions

NASH: Non-alcoholic steatohepatitis.